Our Programmes
We are developing a Drug-Eluting Bead (CellBead Neuro) for the treatment of neurological trauma and neurological degeneration.
Accessibility information | Access Keys


We are developing a Drug-Eluting Bead (CellBead Neuro) for the treatment of neurological trauma and neurological degeneration.
Biocompatibles International plc is a leading medical technology company in the field of drug device combination products, operating through two businesses. CellMed is developing a bead product for cosmetic dermatology and a Drug-Eluting Bead product for the treatment of stroke, based on proprietary stem cell technology. Biocompatibles UK supplies bead and Drug-Eluting Bead products, primarily for use in oncology, and supplies polymer for Medtronic's Endeavor® drug-eluting stent product. Our strategic partners include Angiodynamics Inc, Medtronic Inc, Merz AG and Terumo Corporation.
Drug-Eluting Beads Agreement with Eisai Co. Ltd - 16/05/2008
Proposed Dividend, based on Royalty Income - 15/05/2008
Interim Management Statement - 22/04/2008